Cleansing Options in Out-Patient Setting to Improve Tolerance (COOP SIT) Trial
Cleansing Options in Outpatient Setting to Improve Tolerance (COOP SIT) Trial
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years and older
- Sex
- All sexes
- Healthy volunteers
- Accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Procedures mentioned: Pills, Questionnaires
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "The purpose of this research is to compare patient preferences for two bowel preparation options: low-volume tablets (Suflave/Sutab) versus the standard colon preparation using Golytely (polyethylene glycol)."
- "Surveys will be conducted both before and after the procedures."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study compares two ways to clean out the bowel before a colonoscopy, a test that looks inside the colon: Suflave/Sutab and the standard prep, Golytely. It is for adults with a scheduled colonoscopy that does not require a hospital stay. The study checks which prep patients prefer, how easy it is to finish, and how well it cleans the bowel.
The purpose of this research is to compare patient preferences for two bowel preparation options: low-volume tablets (Suflave/Sutab) versus the standard colon preparation using Golytely (polyethylene glycol). The study aims to enroll approximately 300 patients, who will be randomly assigned to one of the two preparation methods in a 2:1 ratio prior to their scheduled colonoscopy appointments. Surveys will be conducted both before and after the procedures. This project will be conducted over a 12-month period and seeks to compare patient experience of both preparation methods in an outpatient setting. The study will evaluate the rate of preparation completion, patient satisfaction, tolerance of the solutions, and the endoscopic adequacy of each method. Eligible participants are patients aged 18 or older with upcoming colonoscopy appointments who can provide informed consent in English or Spanish. There is no health risks associated with this study, as both bowel preparation methods are FDA-approved and commonly used in clinical practice.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Adults scheduled for a colonoscopy without a hospital stay. The study lists the age limit as 18 or older in one place and over 18 in another.
- Able to understand and agree to join the study in English or Spanish.
- People who have had colon or rectal cancer or past surgery may still join.
Who can't join
- Under age 18.
- Pregnant or breastfeeding.
- Unable to give consent to join the study.
- In jail or prison.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * Adults over age of 18 years undergoing outpatient colonoscopy for various indications, ability to consent in English or Spanish. Patients will still be allowed to join if there is a history of colorectal cancer or previous surgery Exclusion Criteria: * Patient is less than 18 years of age, any pregnant or nursing women, unable to consent, or patient is incarcerated.
Study sites (1)
GA
- Morehouse School of Medicine · Atlanta, GA 30310Jesus Luevano, M.D. · Study contact · 404-971-9018 · jluevanojr@msm.eduJulia Liu, M.D. · Study contact · 404-756-1389 · jjliu@msm.eduJesus Luevano Jr., M.D. · Principal investigatorJulia Liu, M.D. · Sub-investigatorMore trials in Atlanta